Clik here to view.
MassDevice.com +5 | The top 5 medtech stories for December 16, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Crowd-funded startup Scanadu to drop support of Scout ‘tricorder’ device
Kickstarted medical device startup Scanadu, which produces the Scout diagnostic tool, said it will drop support for the Scout devices beginning May 15 next year. The Scanadu Scout is a sensor-packed...
View ArticleClik here to view.
TransEnterix opens robot-assisted surgery training and R&D center in Milan
TransEnterix (NYSE:TRXC) said today it opened a new robotic surgery training and research & development center in Milan, Italy. The facility, named the TransEnterix Milan Robotic Surgery Center,...
View ArticleClik here to view.
Bio-Techne invests $43m, partners with Astute Medical
Life sciences research and diagnostics company Bio-Techne said this week it completed a $43 million equity investment in Astute Medical, with an option to further expand the relationship. Bio-Techne...
View ArticleClik here to view.
Carestream Health wins $571m DoD contract
Carestream Health today won a $571 million contract with the Department of Defense to supply it with radiology systems, accessories and training, according to a DoD release. The 5-year...
View ArticleClik here to view.
FDA issues Class I recall for select Greatbatch offset cup impactors
The FDA today issued a Class I recall for a select amount of Greatbatch Medical (NYSE:GB) standard offset cup impactors designed for use in hip joint replacements over issues with inadequate...
View ArticleClik here to view.
US FDA explains approach to medical device post-market “emerging signals”
By Stewart Eisenhart, Emergo Group The US Food and Drug Administration has published final guidance explaining how and when the agency notifies the public of information such as adverse events...
View ArticleClik here to view.
Sweden’s SCA buys BSN Medical for $2.8B
Swedish hygiene and forest products maker Svenska Cellulosa Aktiebolaget won out over private equity rivals in the race for BSN Medical, with SCA agreeing to pay nearly $2.82 billion (€2.7 billion) for...
View ArticleClik here to view.
Chinese VCs Vivo Capital, ZQ Capital lead syndicate in Angiotech acquisition
Angiotech Pharmaceuticals, which rebranded in 2013 as Surgical Specialties Corp., said today that it agreed to be acquired by a syndicate led by Chinese venture capital shops Vivo Capital and ZQ...
View ArticleClik here to view.
Indian anti-trust regulators approve $25B Abbott-St. Jude Medical tie-up
Anti-trust regulators in India joined their counterparts in the European Union in granting conditional approval for the $25 billion tie-up of Abbott (NYSE:ABT) and St. Jude Medical (NYSE:STJ). In a...
View ArticleClik here to view.
Appeals court denies ex-Cyberonics rep’s False Claims Act lawsuit
A federal appeals court last week denied a former Cyberonics sales rep’s bid to reinstate a File Claims Act suit, finding that plaintiff Andrew Hagerty failed to produce enough evidence to back his...
View ArticleClik here to view.
Japan approves Novocure’s Optune brain cancer treatment
Novocure (NSDQ:NVCR) said today that the Japanese Ministry of Health, Labor and Welfare has approved its tumor treating fields delivery system, Optune, for adult patients with supra-tentorial...
View ArticleClik here to view.
Brainstorm readies phase III trial for NurOwn stem cell treatment for ALS
Brainstorm Cell Therapeutics (NSDQ:BCLI) said today that it’s preparing for a phase III trial of its NurOwn stem cell treatment, after meeting with the FDA about a biologic license application. The...
View ArticleClik here to view.
GSK launches phase III trial for inhaled triple combination therapy
GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) said today that they launched a phase III trial evaluating the triple combination therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) in...
View ArticleClik here to view.
Stryker reaches new metal-on-metal hip implant settlement deal
Stryker (NYSE:SYK) said today that it, and its Howmedica Osteonics subsidiary have reached a compensation agreement for patients who had revision surgery to correct issues with its recalled Rejuvenate...
View ArticleClik here to view.
Amgen wins recommendation for single injection Repatha device
Amgen (NSDQ:AMGN) said today that the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a positive opinion for its Repatha single monthly injection device. The device is...
View ArticleClik here to view.
China’s Microport puts $15m into Lombard Medical
Lombard Medical Technologies (NSDQ:EVAR) said today that China’s MicroPort Orthopedics invested $15 million as part of a partnership deal between the 2 companies. Through the partnership, Lombard will...
View ArticleClik here to view.
Cerus raises funds for phase III trial of Intercept red blood cell system
Cerus Corporation (NSDQ:CERS) said today that it exercised $10.8 million in additional options from its contract with the Biomedical Advanced Research & Development Authority, a part of the U.S....
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for December 19, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Halt Medical touts BCBS reimbursement win in South Carolina
Halt Medical said today that it won coverage from Blue Cross Blue Shield of South Carolina for procedures using its Acessa System to remove fibroids. Acessa uses radiofrequency ablation guided by...
View Article